GlassScriptPhysician profile
Jay S Robertson
NPI 1467869354
$15,702.31
in general payments reported to CMS, 2019-2025
27 companies · $1,307 in 2025
The $1,307 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,128 · 2020: $6,008 · 2021: $841 · 2022: $2,202 · 2023: $659 · 2024: $557 · 2025: $1,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,724 · Travel and Lodging: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,724.32 |
| Travel and Lodging | $798.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,178.95 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $2,511.64 | 2019-2023 | Phasix Mesh |
| Medtronic, INC. | $1,214.20 | 2025 | Venaseal |
| Globus Medical, INC. | $970.06 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $449.22 | 2019 | |
| Tela Bio, INC. | $151.69 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Conmed Corporation | $133.62 | 2022 | |
| Becton, Dickinson and Company | $123.36 | 2023-2025 | Phasix Mesh, Arista Ah Flexitip |
| Organogenesis INC. | $119.97 | 2022-2024 | Puraply |
| Kci USA, INC. | $99.45 | 2019 | |
| Integra Lifesciences Corporation | $90.84 | 2020-2024 | Integra, Omnigraft, Surgimend |
| Abbvie INC. | $85.67 | 2021 | |
| Innocoll Pharmaceuticals Limited | $70.15 | 2021-2022 | |
| Ethicon US, LLC | $69.59 | 2021-2023 | Pds |
| Myriad Genetic Laboratories, INC. | $58.89 | 2024 | Myrisk |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $53.55 | 2024 | Quikclot |
| Pacira Pharmaceuticals Incorporated | $46.14 | 2024 | Exparel |
| Lsi Solutions INC | $44.09 | 2022 | |
| Focal Therapeutics, INC. | $42.22 | 2020 | |
| Acell, INC. | $41.98 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $29.82 | 2025 | |
| Eusa Pharma (US) LLC | $25.81 | 2022 | |
| Polynovo North America LLC | $21.67 | 2024 | Novosorb Btm |
| Elucent Medical | $21.66 | 2025 | |
| Portola Pharmaceuticals, LLC | $18.61 | 2019 | |
| Allergan, INC. | $15.45 | 2021 | |
| Hologic Sales and Service, LLC | $14.01 | 2024 | Localizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.